$3.57
1.11% day before yesterday
Nasdaq, Dec 27, 10:01 pm CET
ISIN
US82657M1053
Symbol
SGHT

Sight Sciences Inc Stock price

$3.57
-0.34 8.70% 1M
-2.97 45.41% 6M
-1.59 30.81% YTD
-2.29 39.08% 1Y
-14.89 80.66% 3Y
-29.93 89.34% 5Y
-29.93 89.34% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.04 1.11%
ISIN
US82657M1053
Symbol
SGHT
Sector

Key metrics

Market capitalization $181.19m
Enterprise Value $97.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.23
P/S ratio (TTM) P/S ratio 2.28
P/B ratio (TTM) P/B ratio 1.89
Revenue growth (TTM) Revenue growth -3.99%
Revenue (TTM) Revenue $79.54m
EBIT (operating result TTM) EBIT $-49.71m
Free Cash Flow (TTM) Free Cash Flow $-26.13m
Cash position $118.56m
EPS (TTM) EPS $-1.01
P/E forward negative
P/S forward 2.23
EV/Sales forward 1.21
Short interest 2.67%
Show more

Is Sight Sciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Sight Sciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Sight Sciences Inc forecast:

2x Buy
25%
6x Hold
75%

Analyst Opinions

8 Analysts have issued a Sight Sciences Inc forecast:

Buy
25%
Hold
75%

Financial data from Sight Sciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
80 80
4% 4%
100%
- Direct Costs 12 12
7% 7%
15%
68 68
3% 3%
85%
- Selling and Administrative Expenses 100 100
12% 12%
125%
- Research and Development Expense 17 17
12% 12%
22%
-49 -49
21% 21%
-62%
- Depreciation and Amortization 0.58 0.58
54% 54%
1%
EBIT (Operating Income) EBIT -50 -50
21% 21%
-63%
Net Profit -50 -50
18% 18%
-63%

In millions USD.

Don't miss a Thing! We will send you all news about Sight Sciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sight Sciences Inc Stock News

Neutral
GlobeNewsWire
9 days ago
Budget impact analysis published in the Expert Review of Ophthalmology journal Budget impact analysis published in the Expert Review of Ophthalmology journal
Neutral
GlobeNewsWire
about one month ago
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced that it will present at the upcoming Piper Sandler 36th Annual Healthcare Conference, in New York, NY.
Neutral
Seeking Alpha
about 2 months ago
Sight Sciences, Inc. (NASDAQ:SGHT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Philip Trip Taylor - Investor Relations Paul Badawi - Co-Founder & Chief Executive Officer Alison Bauerlein - Chief Financial Officer Matt Link - Chief Commercial Officer Conference Call Participants Macauley Kilbane - William Blair Phil Dantoin - Piper Sandler Nelson Cox - Lake...
More Sight Sciences Inc News

Company Profile

Sight Sciences, Inc. is a medical device company, which engages in the provision of glaucoma implants for treatment of irreversible blindness. It also develops pharmaceuticals, drug delivery systems, and diagnostics for the treatment of ophthalmic conditions. The firms products include viscosurgical system and trabeculotomy instrument. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Paul Badawi
Employees 214
Founded 2011
Website www.sightsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today